ImmunoPrecise Antibodies : Partners on Launch of SARS-CoV-2 Nanomedicine Therapy Program
Innovative, novel approach to treat and protect against SARS-CoV-2 using thermoresponsive virus-targeting nanoparticles as an inhalation medicine Program includes... | January 29, 2021
Source: marketscreener.com